Verrica Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verrica Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Verrica Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.01M, a 22.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.01M -$295K -22.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.08M -$290K -21.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.16M -$285K -19.8% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $1.34M -$174K -11.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.3M -$282K -17.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.37M -$176K -11.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.44M -$165K -10.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.51M -$153K -9.18% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.58M -$141K -8.18% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.55M -$232K -13% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.61M -$228K -12.4% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.67M -$225K -11.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.72M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $1.78M +$1.74M +3856% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.84M +$1.73M +1554% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $1.89M +$1.71M +962% Sep 30, 2020 10-Q 2020-11-09
Q1 2020 $45K -$230K -83.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $111K -$193K -63.5% Dec 31, 2019 10-K 2021-03-17
Q3 2019 $178K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $245K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $275K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $304K Jan 1, 2019 10-K 2021-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.